Written answers
Tuesday, 25 September 2012
Department of Health
Medicinal Products Licensing
Martin Ferris (Kerry North-West Limerick, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
To ask the Minister for Health if his attention has been drawn to the improvement in the condition of Cystic Fibrosis patients who are treated with a new drug Kalydeco. [40317/12]
Martin Ferris (Kerry North-West Limerick, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
To ask the Minister for Health when he will license Kalydeco in order that Cystic Fibrosis sufferers may be treated with the drug. [40318/12]
Róisín Shortall (Dublin North West, Labour)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 433 and 434 together.
The HSE has recently received an application for Kayldeco's inclusion under the Community Drugs Scheme. In accordance with normal procedures, The National Centre for Pharmoeconomics will be conducting a Health Technology Assessment on the product before any reimbursement decision is made by the HSE.
No comments